End-Stage Renal Disease Perspective

 
 
  • ERA-EDTA 2021 Read clinically focused news coverage of key developments from ERA-EDTA 2021
  • Palliative Care Update for Clinicians Timely initiation of palliative care services is a challenge, especially for those with noncancer diagnoses, but recent studies offer novel approaches to end-of-life care planning across settings.
  • ISN 2021 Read clinically focused news coverage of key developments from ISN 2021
  • Organ Harvesting's Troubled Past — and Complicated Present With the rise of organ transplantation came difficult ethical questions on race, economics, and the meaning of life.
  • NKF 2021 Read clinically focused news coverage of key developments from the virtual NKF 2021 Spring Clinical Meetings
  • SGLT2 Inhibitors in T1D: 'People Are Using Them Now'   Dr Anne Peters talks about what you need to know regarding off-label use of SGLT2 inhibitors in type 1 diabetes.
  • What You Don't Know About Beta-Blockers and Hemodialysis A new look at the literature turned up a finding that surprised this nephrologist.
  • Lawsuit: Doctor Leaked Private Information to Patient's Family Treating patients from the same family who live together can raise your risk for privacy violations.
  • Does Oxygenated Cold Perfusate Improve Transplant Outcomes? If ischemia is a barrier to organ preservation, will the addition of oxygen to cold preservation solutions improve renal transplant outcomes?
  • Which Antidiabetic Drug Class is Most Renoprotective? In a clash of the antidiabetic drug titans, which class demonstrates the most renoprotection?
  • ESC 2020 DAPA-CKD: SGLT2 Inhibitors 'The Beta-Blockers for the Kidneys'   Nephrologists Jennie Lin and Leslie Gewin discuss the effects of dapagliflozin in patients with CKD. How do the DAPA-CKD findings fit with the CREDENCE data on SGLT2 inhibitors?
  • The Kidney and COVID-19: What We Know so Far   Nephrologists Matthew Sparks and Samira Farouk, of the Freely Filtered podcast, discuss the kidney effects of COVID-19 -- what is and isn't clear in patients with and without preexisting kidney disease.
  • Could a VA Directive Overhaul Kidney Care? Directive 1053 may have gotten lost in the pandemic news, but it could have widespread implications for the management of CKD by nephrologists and primary care. Tejas Desai, MD, takes a closer look.
  • ERA-EDTA 2020 Read clinically focused news coverage of key developments from ERA-EDTA 2020
  • NKF 2020 Read clinically focused news coverage of key developments from NKF 2020
  • ISN 2020 Read clinically focused news coverage of key developments from ISN 2020
  • Cardios, Nephros, PCPs -- We're All Diabetologists Now Newer diabetes medications are proving effective in reducing CV events, hospitalizations for heart failure, and progression to dialysis. So where do these drugs belong?
  • ACIP 2020 Child/Teen Immunization Schedule: The Highlights A quick tour of key changes in the 2020 ACIP child/adolescent immunization schedule.
  • Dialysis Industry Mergers: Profits Rise as Outcomes Worsen An economic analysis of the dialysis industry shows how the usual benefits of mergers are negated in the healthcare industry by imprudent financial incentives and lack of true competitive market forces.
  • Palliative Care in End-Stage Renal Disease In this case, a social worker must respond to a patient who expresses that she would like to discontinue dialysis and knows that doing so means she will die soon.